Sawai Sets Out US Recalibration
Consolidating US Manufacturing Operations In Minnesota And Strengthening Portfolio
Sawai Pharmaceutical has major plans for its US business that include consolidating its manufacturing operations at a single site and bolstering its pipeline and portfolio, Sawai president Kenzo Sawai tells Generics Bulletin in an exclusive interview.
You may also be interested in...
Japan’s Sawai has laid out its mid- and long-term ambitions in a new company business plan, spanning both its local and overseas operations.
Sawai has overcome obstacles in its home market to register growth in Japan in the first nine months of its current financial year. However, the firm has seen its overall sales and profits dragged down by a slump in the US.
In the face of both local and global pressures, Japan’s Sawai Pharmaceutical is holding steady by relying on its core strengths, company president Kenzo Sawai tells Generics Bulletin in the first part of an exclusive two-part interview.